BORASCHI, DIANA
 Distribuzione geografica
Continente #
AS - Asia 2.426
NA - Nord America 1.403
EU - Europa 534
SA - Sud America 447
AF - Africa 49
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.862
Nazione #
US - Stati Uniti d'America 1.313
SG - Singapore 1.087
CN - Cina 477
BR - Brasile 362
HK - Hong Kong 289
VN - Vietnam 260
IT - Italia 156
FR - Francia 147
KR - Corea 79
BD - Bangladesh 60
FI - Finlandia 47
JP - Giappone 45
DE - Germania 44
CA - Canada 39
IN - India 38
NL - Olanda 35
GB - Regno Unito 29
AR - Argentina 23
MX - Messico 18
IL - Israele 15
CO - Colombia 14
EC - Ecuador 14
PL - Polonia 12
ID - Indonesia 11
MA - Marocco 11
TR - Turchia 11
SA - Arabia Saudita 10
AT - Austria 9
CL - Cile 9
CR - Costa Rica 8
EG - Egitto 8
ES - Italia 8
LT - Lituania 8
PE - Perù 8
ZA - Sudafrica 8
JM - Giamaica 7
UZ - Uzbekistan 7
IE - Irlanda 6
KE - Kenya 6
TN - Tunisia 6
UA - Ucraina 6
VE - Venezuela 6
IQ - Iraq 5
KZ - Kazakistan 5
NP - Nepal 5
PA - Panama 5
PK - Pakistan 4
PY - Paraguay 4
SE - Svezia 4
UY - Uruguay 4
CZ - Repubblica Ceca 3
GT - Guatemala 3
MY - Malesia 3
RS - Serbia 3
SN - Senegal 3
BO - Bolivia 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
CH - Svizzera 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GF - Guiana Francese 1
GP - Guadalupe 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
SI - Slovenia 1
TC - Turks e Caicos 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 4.862
Città #
Singapore 645
Santa Clara 459
Hong Kong 288
Hefei 193
San Jose 170
Lauterbourg 116
Ashburn 109
Beijing 95
Ho Chi Minh City 86
Hanoi 81
Seoul 78
Dallas 63
Los Angeles 50
Tokyo 32
São Paulo 31
Helsinki 26
New York 26
Milan 25
Buffalo 19
Frankfurt am Main 19
Council Bluffs 14
Lappeenranta 13
Marigliano 12
Rio de Janeiro 12
Minamishinagawa 11
Da Nang 10
Orem 10
Phoenix 10
Campinas 9
Chennai 9
Nuremberg 9
Porto Alegre 9
Rome 9
Brasília 8
Chicago 8
London 8
Montreal 8
Naples 8
Turku 8
Warsaw 8
Atlanta 7
Brooklyn 7
Cairo 7
Haiphong 7
Tashkent 7
Toronto 7
Belo Horizonte 6
Guayaquil 6
Houston 6
Hải Dương 6
Ribeirão Preto 6
San José 6
Bengaluru 5
Biên Hòa 5
Brescia 5
Changsha 5
Falkenstein 5
Florence 5
Kingston 5
Lima 5
Medellín 5
Nairobi 5
Nha Trang 5
Nova Iguaçu 5
Riyadh 5
São Gonçalo 5
Thái Nguyên 5
Bauru 4
Boardman 4
Campo Grande 4
Casablanca 4
Curitiba 4
Denver 4
Detroit 4
Dhaka 4
Dublin 4
Guarulhos 4
Istanbul 4
Jeddah 4
Las Vegas 4
Marília 4
Medford 4
Montevideo 4
New Delhi 4
Newark 4
Osasco 4
Piscataway 4
Portsmouth 4
Potenza 4
Quận Một 4
Santo André 4
São Bernardo do Campo 4
The Bronx 4
Vienna 4
Amsterdam 3
Araguari 3
Asunción 3
Avellino 3
Baghdad 3
Bari 3
Totale 3.083
Nome #
Engineered nanoparticles. How brain friendly is this new guest? 105
Interaction of nanoparticles with endotoxin Importance in nanosafety testing and exploitation for endotoxin binding 104
Towards bio-compatible magnetic nanoparticles Immune-related effects, in-vitro internalization, and in-vivo bio-distribution of zwitterionic ferrite nanoparticles with unexpected renal clearance 91
Addressing Nanomaterial Immunosafety by Evaluating Innate Immunity across Living Species 76
Personalised Profiling of Innate Immune Memory Induced by Nano-Imaging Particles in Human Monocytes 74
Profiling the Course of Resolving vs. Persistent Inflammation in Human Monocytes: The Role of IL-1 Family Molecules 74
Methodological Approaches To Assess Innate Immunity and Innate Memory in Marine Invertebrates and Humans 73
Probing the immune responses to nanoparticles across environmental species. A perspective of the EU Horizon 2020 project PANDORA 71
Endotoxin contamination: a key element in the interpretation of nanosafety studies 69
Regulation of innate receptors and IL-18 in hepatocytic cells is altered by environmental particles. 68
IL-1 Family 66
Induction of Innate Immune Memory by Engineered Nanoparticles: A Hypothesis That May Become True 66
Direct LC-MS/MS Analysis of Extra- and Intracellular Glycerophosphoinositol in Model Cancer Cell Lines 66
Innate Memory Reprogramming by Gold Nanoparticles Depends on the Microbial Agents That Induce Memory 66
Innate and germline immune memory: specificity and heritability of the ancient immune mechanisms for adaptation and survival 64
Structural disconnectivity in postoperative delirium: A perioperative two-center cohort study in older patients 61
Effects of nano-and microplastics in the development of immune memory in the ascidian Ciona robusta 60
Interaction between nanomaterials and the innate immune system across evolution 59
Environmental stress and nanoplastics' effects on Ciona robusta: regulation of immune/stress-related genes and induction of innate memory in pharynx and gut 59
Development of biologicals for the therapy of lupus erythematosus 56
IL-1 family cytokines and receptors in IgG4-related disease. 56
Primary and memory response of human monocytes to vaccines: Role of nanoparticulate antigens in inducing innate memory 54
Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression? 54
A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses 52
ImmuNapoli 2019 52
Neutrophil apoptosis in autoimmune Fas-defective MRL lpr/lpr mice 51
New approaches to anti-bacterial mucosal immunization through targeted modulation of innate immunity mechanisms 51
Interaction between Macrophages and Nanoparticles: In Vitro 3D Cultures for the Realistic Assessment of Inflammatory Activation and Modulation of Innate Memory 50
Suitability of in vitro Immunotoxicity Methods for Assesment of Nanomaterials 48
Cytokines and soluble receptors of the IL-1 family in Schnitzler syndrome. 48
Concern-driven integrated approaches to nanomaterial testing and assessment - report of the NanoSafety Cluster Working Group 10 48
Poverty-Related Disease College: a virtual African-European network to build research capacity. 47
The association between frailty and MRI features of cerebral small vessel disease 47
IL-1 family cytokines and monocytes/macrophages in the regulation of inflammation. 47
Robust Immune Response Induced by Schistosoma mansoni TSP-2 Antigen Coupled to Bacterial Outer Membrane Vesicles 46
Induction of Innate Immune Memory by Engineered Nanoparticles in Monocytes/Macrophages: From Hypothesis to Reality 45
Innate Immune Memory in Invertebrate Metazoans: A Critical Appraisal 44
Surface Exposure of PEG and Amines on Biodegradable Nanoparticles as a Strategy to Tune Their Interaction with Protein-Rich Biological Media 43
Cerebral microbleeds are not associated with postoperative delirium and postoperative cognitive dysfunction in older individuals 43
The IL-1 family cytokines and receptors in autoimmune diseases 43
In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii 42
IL-1 family nomenclature 41
IL-1 family cytokines and soluble receptors in systemic lupus erythematosus 37
The Impact of Nanoparticles on Innate Immune Activation by Live Bacteria 37
Optimising the use of commercial LAL assays for the analysis of endotoxin contamination in metal colloids and metal oxide nanoparticles 37
Assessing the Immunosafety of Engineered Nanoparticles with a Novel in Vitro Model Based on Human Primary Monocytes. 36
Assessing Immunological Memory in the Solitary Ascidian Ciona robusta 35
Induction of long-term immunity against Respiratory Syncytial Virus glycoprotein by an osmotic polymer nanocarrier 35
MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation 34
Optimising the use of commercial LAL assays for the analysis of endotoxin contamination in metal colloids and metal oxide nanoparticles 33
Transcriptomic profiling of the development of the inflammatory response in human monocytes in vitro 32
Innate Immune Memory: The Latest Frontier of Adjuvanticity 32
From monocytes to M1/M2 macrophages: Phenotypical vs. functional differentiation 31
Preface 31
Cytokine receptors 31
Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific 31
Concepts for nano-delivery of therapeutic immunomodulatory agents 30
Perspectives in immunopharmacology: The future of immunosuppression 30
From Antigen Delivery System to Adjuvanticy: The Board Application of Nanoparticles in Vaccinology. 30
Cytokine gene transfer in the therapy of autoimmune diseases 30
Free circulating interleukin-18 is increased in Schnitzler syndrome: a new autoinflammatory disease? 30
Chimeric plant virus particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice 30
Balance between autocrine IL-1² and caspases defines life vs. death of PMN 29
ImmuNapoli 2016 29
Nanoparticles and innate immunity: new perspectives on host defence. 29
Nano-immunosafety: approaches to in vitro assessment 28
IL-37: a new anti-inflammatory cytokine of the IL-1 family 28
Exploring the interaction of nanomedicines with the human immune system, Assessing immunosafety and investigating preventive/therapeutic targeting. 28
Endotoxin contamination in nanomaterials leads to the misinterpretation of immunosafety results 28
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis 28
Nanoparticles and the immune system: safety and effects 28
Vaccines of the Future: The Role of Inflammation and Adjuvanticity 28
Modulation of defence cell functions by nano-particles in vitro. 27
IL-1 family nomenclature (vol 11, pg 973, 2010) 27
Assessing immunosafety of nanomaterials. Cell-based modelling of inflammatory responses to predict putative risks for human health 27
Optimising response to vaccination in the elderly: the case of influenza 27
Towards nanotechnology regulation-Publish the unpublishable 26
Bovine colon organoids: From 3D bioprinting to cryopreserved multi-well screening platforms 26
Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria 26
Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain 25
The Gracefully Aging Immune System 25
Pharmacological strategies using biologics as immunomodulatory agents 25
Specific immune response to HBsAg is enhanced by ²-glucan oligosaccharide containing an ±-(1 3)-linked bond, and biased towards M2/Th2 25
UPREGULATION OF IL-1/IL-18 FAMILY CYTOKINES AND RECEPTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS 25
REGULATION OF IL-1/IL-18 FAMILY CYTOKINES AND RECEPTORS BY ²-GLUCANS: PROMOTION OF NON-INFLAMMATORY RESPONSES IN EPITHELIAL CELLS AND MONOCYTES 25
Nanoparticles and the Immune System: Safety and Effects 25
Innate Reactivity of Intestinal Mucosal Cells: Regulation of the Expression of IL-1², IL-18 and TIR8/SIGIRR Genes by Engineered Nanoparticles 25
The immunostimulatory effect of IL-1 beta in vivo is blocked by antisense peptides complementary to the loop sequence 163-171 25
Immunosenescence and vaccine failure in the elderly: Strategies for improving response 24
Modulation of defence cell functions by nano-particles in vitro 24
How Innate and Adaptive Immunity Work 24
The problem of nanosafety: how to assess the fate of nano-bio interaction and predict risk. 24
THE PATHOLOGICAL ROLE OF IL-18 IN LYMPHOID ORGANS OF AUTOIMMUNE MRL lpr/lpr MICE 24
Glycosylation enhances functional stability of the chemotactic cytokine CCL-2. 24
The need for addressing immunisafety of nanomaterials 24
Modulation of macrophage activation programming during inflammation. Integrated profiling in an in vitro model of human monocyte reactivity 24
Immunosafety of engineered nanoparticles: methods implementation for the development of nanomedicines 24
Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria 23
Innate immune memory: Time for adopting a correct terminology 23
Interaction of nanoparticles with the immune system 23
Totale 4.111
Categoria #
all - tutte 17.935
article - articoli 11.895
book - libri 295
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.332
Totale 32.457


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202459 0 0 0 0 0 0 0 0 12 8 22 17
2024/20251.875 4 7 140 81 468 45 50 68 77 55 472 408
2025/20262.946 125 282 314 494 526 77 403 159 160 187 145 74
2026/2027111 111 0 0 0 0 0 0 0 0 0 0 0
Totale 4.991